RxNorm Names
LORATADINE tablet
[Premier Value]
Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=778a6979-ea47-4381-8c40-84b3c2325a7e| Category | DEA Schedule | Marketing Status |
|---|---|---|
| HUMAN OTC DRUG LABEL | Abbreviated New Drug Application |
USES
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- runny nose
- itchy, watery eyes
- sneezing
- itching of the nose or throat
WARNINGS
Ask a doctor before use if you have
liver or kidney disease. Your doctor should determine if you need a different dose.
When using this product
do not take more than directed. Taking more than directed may cause drowsiness.
DIRECTIONS
| adults and children 6 years and over | 1 tablet daily; not more than 1 tablet in 24 hours |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
OTHER INFORMATION
- store between 20 and 25° C (68 and 77° F)
- protect from excessive moisture
- TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.
- TAMPER EVIDENT: DO NOT USE IF IMPRINTED SEAL IS BROKEN OR MISSING FROM BOTTLE.
PRINCIPAL DISPLAY PANEL
Original Prescription Strength
- Sneezing
- Runny Nose
- Itchy, Watery Eyes
- Itchy Throat or Nose
COMPARE TO THE ACTIVE INGREDIENT OF CLARITIN®†
*When taken as directed. See Drug Facts Panel.
†This product is not manufactured or distributed by Schering-Plough HealthCare Products, Inc. CLARITIN® is a registered trademark of Schering Corporation.
| LORATADINE
loratadine tablet |
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
| Labeler - Premier Value (101668460) |
| Registrant - Ranbaxy Pharmaceuticals Inc. (937890044) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| Ohm Laboratories Inc. | 051565745 | manufacture(68016-526) | |
Revised: 07/2012
Document Id: ff6c4d5a-54af-4dde-b50c-feead82efbc8
Set id: 778a6979-ea47-4381-8c40-84b3c2325a7e
Version: 1
Effective Time: 20120720
Premier Value
Review RxNorm Normal Forms
